ESZTER VARGA: Open Payments
NPI 1215368949 · ARLINGTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$381 in 19 payments from 11 companies in 2025. Trend: 2023 $333 · 2024 $372 · 2025 $381
Food & beverage: $381
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $89 |
| Collegium Pharmaceutical, Inc. | 3 | $65 |
| ALK-Abello, Inc | 2 | $56 |
| Supernus Pharmaceuticals, Inc. | 2 | $34 |
| Exact Sciences Corporation | 1 | $30 |
| Novo Nordisk Inc | 1 | $20 |
| Abbott Laboratories | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| PFIZER INC. | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: VRAYLAR, Jornay PM, NEFFY, Qelbree, Cologuard Collection Kit, Wegovy, FREESTYLE LIBRE 3, UBRELVY.
Industry payments across VA — which companies pay providers there.
